NeuroHELP

Portable Neurotechnology for Forecasting Epileptic Seizures

Health Tech & Life Sciences
Active
Pre-Funding Be'er Sheva, Israel Founded 2018
Last updated 2026-06-18
Total raised
Stage
Pre-Funding
Founded
2018
Headcount
12
HQ
Be'er Sheva, Israel
Sector
Health Tech & Life Sciences

About

NeuroHELP is developing a simple, portable EEG system that can be used by patients with epilepsy on a daily basis. The system alerts patients before a seizure occurs and sends the processed information to the caregivers. NeuroHELPs algorithmic solution involves automatic tools for signal preprocessing and artifact removal, advanced nonlinear measures of brain activity that reflect the underlying dynamics, and machine learning techniques for integrating the information and assessing the likelihood of an upcoming seizure. The algorithms have already been designed, implemented, and tested offline on a large database of EEGs from patients with epilepsy, with highly accurate results. The system can also assist in optimizing the type, dosage, and frequency of drugs given to the patient. The technology is designed to improve the quality of life for individuals with epilepsy by reducing the anxiety caused by the unforeseeable occurrence of seizures and allowing for advance preparation before a seizure ensues.

Q&A

What is NeuroHELP's primary focus?
NeuroHELP is developing a portable neurotechnology system designed to forecast epileptic seizures and alert patients and caregivers in advance.
What technology does NeuroHELP utilize in its system?
NeuroHELP's system incorporates automatic tools for signal preprocessing and artifact removal, advanced nonlinear measures of brain activity, and machine learning techniques to assess the likelihood of an upcoming seizure.
What is the current product stage of NeuroHELP's technology?
NeuroHELP's product is currently in the clinical trial stage.
When was NeuroHELP founded?
NeuroHELP was founded in January 2018.
How many employees does NeuroHELP have?
NeuroHELP has 11-50 employees.
What is NeuroHELP's current funding stage?
NeuroHELP is currently in the Pre-Funding stage.
What is the primary sector of NeuroHELP?
NeuroHELP's primary sector is Health Tech & Life Sciences.
What is the main benefit of NeuroHELP's technology for patients?
NeuroHELP's technology aims to improve the quality of life for individuals with epilepsy by reducing anxiety caused by unforeseeable seizures and allowing for advance preparation.

Team · 4

Founder · Co-founder & CEO
LinkedIn ↗
Founder · Co-founder & CTO
LinkedIn ↗
Founder · Co-founder and Active Chair Person
LinkedIn ↗
Founder · Co-founder and VP R&D
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Monitors
Technologies
Artificial IntelligenceMachine Learning
Target customers
Industrial ManufacturingDiscrete IndustriesAerospaceHealthcare & Life SciencesHealthcareProviders
Business model
B2B

Tags

epilepsymedical-devicesalert-systemartificial-intelligencehealthcare-providersneurologywearablechildrenalgorithmswearable
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteneuro-help.com/en
LinkedInlinkedin.com/company/79772261

Identifiers & details

Founded2018-1
Employees (exact)12

Radar intelligence

Patents

EPO1

Publications (Crossref)

Works1

Web history (Wayback)

Domainneuro-help.com

Certificate / subdomain footprint

Subdomains2